Preclinical Alzheimer's disease and longitudinal driving decline
暂无分享,去创建一个
Chengjie Xiong | Brian R. Ott | Peggy P. Barco | Elizabeth Mormino | David B. Carr | David M. Holtzman | John C. Morris | Anne M. Fagan | A. Fagan | D. Head | J. Morris | D. Holtzman | D. Holtzman | C. Xiong | D. Carr | Brian L. Ott | E. Grant | C. Roe | E. Mormino | T. Benzinger | B. Ott | G. Babulal | Sarah H Stout | P. Barco | Monique M. Williams | N. Ghoshal | E. Vernon | Ann M. Johnson | Catherine M. Roe | Elizabeth A. Grant | Tammie L.S. Benzinger | Brad Garland | Rebecca Fierberg | M. S. Fague | Ganesh M. Babulal | Denise M. Head | Sarah H. Stout | Elizabeth K. Vernon | Nupur Ghoshal | Brad Garland | Ann Johnson | Rebecca Fierberg | M. Scot Fague | J. Morris | S. H. Stout | J. Morris | J. Morris
[1] J. Morris,et al. Creating a driving profile for older adults using GPS devices and naturalistic driving methodology , 2016, F1000Research.
[2] C. Roe,et al. Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research , 2016, F1000Research.
[3] Brian R. Ott,et al. Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk , 2016, Alzheimer's & Dementia.
[4] A. Fagan,et al. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease , 2015, Alzheimer's & Dementia.
[5] Richard J. Caselli,et al. Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools? , 2014, Alzheimer's & Dementia.
[6] M. Friedrich. Researchers test strategies to prevent Alzheimer disease. , 2014, JAMA.
[7] J. Morris,et al. Exploration of 100 commonly used drugs and supplements on cognition in older adults , 2013, Alzheimer's & Dementia.
[8] A. Fagan,et al. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study , 2013, The Lancet Neurology.
[9] Nazan Aksan,et al. Naturalistic Distraction and Driving Safety in Older Drivers , 2013, Hum. Factors.
[10] R. Katz,et al. Regulatory innovation and drug development for early-stage Alzheimer's disease. , 2013, The New England journal of medicine.
[11] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[12] A. Fagan,et al. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. , 2012, Human molecular genetics.
[13] W. Klunk. Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia , 2011, Neurobiology of Aging.
[14] D. Carr,et al. Predicting Road Test Performance in Drivers with Dementia , 2011, Journal of the American Geriatrics Society.
[15] Joel H. Kramer,et al. Assessment of cognition in early dementia , 2011, Alzheimer's & Dementia.
[16] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[17] Eduard Zaloshnja,et al. Incidence and Total Lifetime Costs of Motor Vehicle–Related Fatal and Nonfatal Injury by Road User Type, United States, 2005 , 2010, Traffic injury prevention.
[18] B. Ott,et al. How does dementia affect driving in older patients? , 2010, Aging health.
[19] J. Morris,et al. Stability of the Clinical Dementia Rating, 1979-2007. , 2009, Archives of neurology.
[20] A. Fagan,et al. Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type. , 2009, Archives of neurology.
[21] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[22] Nathaniel Mercaldo,et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.
[23] M. Carrillo,et al. Early risk assessment for Alzheimer's disease , 2009, Alzheimer's & Dementia.
[24] P Sachdev,et al. Mild neuritic changes are increased in the brains of fatally injured older motor vehicle drivers. , 2007, Accident; analysis and prevention.
[25] Gina N. LaRossa,et al. [11C]PIB in a nondemented population , 2006, Neurology.
[26] Susan A Ferguson,et al. Collisions Involving Senior Drivers: High-Risk Conditions and Locations , 2006, Traffic injury prevention.
[27] Gina N. LaRossa,et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.
[28] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[29] J. Duchek,et al. Longitudinal Driving Performance in Early‐Stage Dementia of the Alzheimer Type , 2003, Journal of the American Geriatrics Society.
[30] A. Dale,et al. Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.
[31] Ana Ivelisse Avilés,et al. Linear Mixed Models for Longitudinal Data , 2001, Technometrics.
[32] Beth T. Stalvey,et al. Older drivers and cataract: driving habits and crash risk. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[33] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[34] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[35] A. Fagan,et al. Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals , 2017, Alzheimer disease and associated disorders.
[36] G. Naglie,et al. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment. , 2016, Journal of Alzheimer's disease : JAD.
[37] J. Morris,et al. Creating a driving profile for older adults using GPS devices and naturalistic driving methodology. , 2016, F1000Research.
[38] Lutz Jäncke,et al. The relation between performance in on-road driving, cognitive screening and driving simulator in older healthy drivers , 2014 .
[39] D. Salmon,et al. The Alzheimer ’ s Disease Centers ’ Uniform Data Set ( UDS ) : The Neuropsychological Test Battery , 2009 .
[40] Yvette I. Sheline,et al. Potential antecedent marker of Alzheimer disease , 2006 .
[41] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[42] Vijaya L. Melnick,et al. Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.
[43] D.,et al. Regression Models and Life-Tables , 2022 .